Clinical biomarker–based biological ageing and the risk of adverse outcomes in patients with chronic kidney disease
In patients with CKD, both KDM-BA acceleration and PhenoAge acceleration were associated with an increased risk of ESKD, CVD and all-cause mortality, and KDM-BA or PhenoAge may be a better predictor on adverse outcomes than LTL.
Authors
- Xiaoqin Gan (ORCID: https://orcid.org/0009-0002-1906-666X)
- Xianhui Qin (ORCID: https://orcid.org/0000-0001-7812-7982)
- Fan Fan Hou (ORCID: https://orcid.org/0000-0003-3117-7418)
- Ziliang Ye (ORCID: https://orcid.org/0000-0001-8314-6977)
- Panpan He (ORCID: https://orcid.org/0000-0003-4238-5837)
- Sisi Yang (ORCID: https://orcid.org/0009-0008-2696-9107)
- Yuanyuan Zhang (ORCID: https://orcid.org/0000-0001-8849-0718)
- Yu Huang (ORCID: https://orcid.org/0000-0003-2560-5674)
- Yanjun Zhang (ORCID: https://orcid.org/0000-0002-9597-2050)
- Hao Xiang (ORCID: https://orcid.org/0000-0003-4823-2890)
Institutions
- Nanfang Hospital (CN)
- National Clinical Research (US)
- Southern Medical University (CN)
Publication Details
- Journal
- Age and Ageing
- Published
- 2024-11-01
- DOI
- https://doi.org/10.1093/ageing/afae245
- Citations
- 10
- Primary Topic
- Dialysis and Renal Disease Management
- Type
- article
- Field-Weighted Citation Impact
- 3.39